The U.S. is planning to set up a system that will allow wholesalers, states and pharmacists to get FDA approval to import certain lower-cost prescription medications from Canada.
US To Allow Drugs From Canada?
New System To Permit Americans To Import Prescription Drugs From Canada
By RICARDO ALONSO-ZALDIVAR Associated Press
WASHINGTON (AP) — The Trump administration said Wednesday it will set up a system to allow Americans to legally import lower-cost prescription drugs from Canada, weakening a longstanding ban that had stood as a top priority for the politically powerful pharmaceutical industry.
Health and Human Services Secretary Alex Azar made the announcement Wednesday morning. Previous administrations had sided with the industry on importation, echoing its concerns that it could expose patients to risks from counterfeit or substandard medications.
Azar, a former drug industry executive, said U.S. patients will be able to import medications safely and effectively, with oversight from the Food and Drug Administration. The administration's proposal would allow states, wholesalers and pharmacists to get FDA approval to import certain medications that are also available here.
It's unclear how soon consumers will see results.
Most patients take affordable generic drugs to manage conditions such as high blood pressure or elevated blood sugars. But polls show concern about the prices of breakthrough medications for intractable illnesses like cancer or hepatitis C infection, whose costs can run to $100,000 or more. And long-available drugs like insulin have also seen price increases that have forced some people with diabetes to ration their own doses.
"For too long American patients have been paying exorbitantly high prices for prescription drugs that are made available to other countries at lower prices," Azar said in a statement that credited President Donald Trump for pushing the idea.
The administration's move comes as the industry is facing a crescendo of consumer complaints over prices, as well as legislation from both parties in Congress to rein in costs.
Trump is supporting a Senate bill to cap medication costs for Medicare recipients and require drugmakers to pay rebates to the program if price hikes exceed inflation. Democrats in the House are pressing for a vote on a bill allowing Medicare to directly negotiate prices on behalf of millions of seniors enrolled in its prescription drug plan. Separately, the Trump administration is pursuing a regulation that would tie what Medicare pays for drugs administered in doctors' offices to lower international prices.
The importation idea won praise from a key lawmaker, Sen. Chuck Grassley, R-Iowa, chairman of the panel that oversees Medicare. Grassley said on Twitter that importation would lower prescription drug costs, and all drugs from abroad must be verified as safe by the FDA. He and Democratic presidential candidate Sen. Amy Klobuchar of Minnesota have a bill to facilitate importation.
Eyeing his reelection campaign, Trump has made lowering prescription drug prices one of his top goals. As a candidate, he called for allowing Americans to import prescription drugs, and recently he's backed a Florida law allowing state residents to gain access to medications from Canada
Drug prices are lower in other economically advanced countries because governments take a leading role in setting prices. But in the U.S., Medicare is not permitted to negotiate with drug companies.
Some experts have been skeptical of allowing imports from Canada, partly from concerns about whether Canadian suppliers have the capacity to meet the demands of the much larger U.S. market.
But consumer groups have strongly backed the idea, arguing that it will pressure U.S. drugmakers to reduce their prices. They also point out that the pharmaceutical industry is a global business and many of the ingredients in medications sold in the U.S. are manufactured abroad.
AARP had pushed hard for the Florida plan, saying it's possible to safely import lower-priced, equally effective drugs and it would promote worldwide price competition.
The drug industry lobby, Pharmaceutical Research and Manufacturers of America, has successfully blocked past efforts in Washington to allow importation. It argues that patients would be at risk of receiving counterfeit or adulterated medications.
In addition to bringing our readers stories about education issues in America, we here at Hispanic Outlook feature news articles on topics both related to and outside of the field of education on our website and in our social media.
Hispanic Outlook is an education magazine in the US available both in print and digital form. Visit https://www.hispanicoutlook.com/education-magazine for information about our latest issue, including our new supplement Physician Outlook.
Hispanic Outlook’s Job Board allows applicants to search for jobs by category, by city and by state. Both Featured and Latest Job Positions are available at https://hispanicoutlookjobs.com/
And for employers, Hispanic Outlook’s Job Board offers a wide variety of posting options. Further information is available at https://hispanicoutlookjobs.com/employer-products/
Other articles from Hispanic Outlook:
Your Money Or Your Life
Imagine you go to a car dealership and receive a modest discount off the sticker price of the car you buy. Then you find out that the dealer got a much bigger rebate on your car as a result of cutting a kickback deal with the car manufacturer—a kickback that they either pocketed outright, told you they “reinvested” so you could save money on your next purchase or kept the lion’s share of for themselves while tossing you a tiny rebate. You’d probably not buy their car and go to a dealership that didn’t take rebates or kickbacks, or decide to skip the car purchase altogether and take the bus. Now imagine that this is the way you purchase—not a car—but life-saving pharmaceuticals and medical devices. It comes down to this: your money or your life. There’s been so much talk about the obscene cost of health care. You’ve seen the headlines—there are too many frivolous law suits, there is…
Read full article here
Is There A Doctor…Anywhere?
Perhaps this has happened to you (and if it hasn't, it might happen soon). You need to see a Doctor, but you’re told you can’t see the Doctor for weeks or maybe even a month. Or maybe your trusted family Doctor has either moved away, died or retired, and an all-purpose medical group has moved into that office. More than likely you’ll have to get used to seeing non-Doctors including nurses and APNs for routine office visits. Unless the projected Physician shortage is reversed, that’s the future of medical care. If that doesn’t sound wrong, how would you feel if you were on trial in a case where your life, liberty or livelihood was on the line, and the only person you could find to argue on your behalf was a paralegal, not a licensed attorney? Unlike an attorney, every time you see a Doctor there’s a chance that his or her skills will discover and treat something that would otherwise severely impact...
Read full article here
Physicians Sound Health Care Alarm
Editor’s Note: Bipartisan Physicians and health care experts gathered at the Free to Care Physician Symposium in Washington, D.C., earlier this year. A white paper1 offering a roadmap drawn by a coalition of organizations made up of working Physicians and industry experts entitled, “Reducing Cost and Waste in American Medicine A Physician-Led Roadmap to Patient-Centered Medical Care,” was presented by authors C. L. Gray, M.D., founder, Physicians for Reform2 and Marion Mass, M.D. co-founder, Practicing Physicians of America3. The following is an abridged version of the white papers premise: “The cost of medical care—and access to medical care itself—now sit atop the list of worries for American households. In years past, the debate over healthcare reform centered on the autonomy of individual patients and their physicians. Who should control the personal and complex process of…
Read full article here
